416 related articles for article (PubMed ID: 1653841)
1. Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin.
Bakry N; Kamata Y; Simpson LL
J Pharmacol Exp Ther; 1991 Sep; 258(3):830-6. PubMed ID: 1653841
[TBL] [Abstract][Full Text] [Related]
2. Chelation of zinc antagonizes the neuromuscular blocking properties of the seven serotypes of botulinum neurotoxin as well as tetanus toxin.
Simpson LL; Coffield JA; Bakry N
J Pharmacol Exp Ther; 1993 Nov; 267(2):720-7. PubMed ID: 8246147
[TBL] [Abstract][Full Text] [Related]
3. The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin.
Simpson LL
J Pharmacol Exp Ther; 1984 Apr; 229(1):182-7. PubMed ID: 6707933
[TBL] [Abstract][Full Text] [Related]
4. Use of pharmacologic antagonists to deduce commonalities of biologic activity among clostridial neurotoxins.
Simpson LL
J Pharmacol Exp Ther; 1988 Jun; 245(3):867-72. PubMed ID: 2455038
[TBL] [Abstract][Full Text] [Related]
5. Tetanus toxin and neuronal membranes: the relationship between binding and toxicity.
Bakry N; Kamata Y; Sorensen R; Simpson LL
J Pharmacol Exp Ther; 1991 Aug; 258(2):613-9. PubMed ID: 1865360
[TBL] [Abstract][Full Text] [Related]
6. Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
Simpson LL; Dasgupta BR
J Pharmacol Exp Ther; 1983 Jan; 224(1):135-40. PubMed ID: 6294275
[TBL] [Abstract][Full Text] [Related]
7. Fragment C of tetanus toxin antagonizes the neuromuscular blocking properties of native tetanus toxin.
Simpson LL
J Pharmacol Exp Ther; 1984 Mar; 228(3):600-4. PubMed ID: 6707911
[TBL] [Abstract][Full Text] [Related]
8. Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins.
Simpson LL
J Pharmacol Exp Ther; 1983 Jun; 225(3):546-52. PubMed ID: 6864519
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
Coffield JA; Bakry N; Zhang RD; Carlson J; Gomella LG; Simpson LL
J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
[TBL] [Abstract][Full Text] [Related]
10. Exchanging the minimal cell binding fragments of tetanus neurotoxin in botulinum neurotoxin A and B impacts their toxicity at the neuromuscular junction and central neurons.
Höltje M; Schulze S; Strotmeier J; Mahrhold S; Richter K; Binz T; Bigalke H; Ahnert-Hilger G; Rummel A
Toxicon; 2013 Dec; 75():108-21. PubMed ID: 23817019
[TBL] [Abstract][Full Text] [Related]
11. The interaction between aminoquinolines and presynaptically acting neurotoxins.
Simpson LL
J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072
[TBL] [Abstract][Full Text] [Related]
12. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
Kalandakanond S; Coffield JA
J Pharmacol Exp Ther; 2001 Mar; 296(3):980-6. PubMed ID: 11181932
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin and tetanus toxin recognize similar membrane determinants.
Simpson LL
Brain Res; 1984 Jul; 305(1):177-80. PubMed ID: 6331597
[TBL] [Abstract][Full Text] [Related]
14. Role of protein kinase C in short-term transmission at the mammalian neuromuscular junction.
Considine RV; Sherwin JR; Simpson LL
J Pharmacol Exp Ther; 1992 Dec; 263(3):1269-74. PubMed ID: 1335062
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
Simpson LL; Coffield JA; Bakry N
J Pharmacol Exp Ther; 1994 Apr; 269(1):256-62. PubMed ID: 8169833
[TBL] [Abstract][Full Text] [Related]
16. [Structure and function of botulinum toxin].
Fujii N
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
[TBL] [Abstract][Full Text] [Related]
17. Bacterial neurotoxins--a thousand years later.
Linial M
Isr J Med Sci; 1995 Oct; 31(10):591-5. PubMed ID: 7591680
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to botulinum toxin.
Coffield JA; Bakry NM; Maksymowych AB; Simpson LL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1509-16. PubMed ID: 10336546
[TBL] [Abstract][Full Text] [Related]
19. Occurrence and distribution of sialic acid residues in developing rat glomerulus: investigations with the Limax flavus and the wheat germ agglutinin.
Wagner P; Roth J
Eur J Cell Biol; 1988 Dec; 47(2):259-69. PubMed ID: 3243283
[TBL] [Abstract][Full Text] [Related]
20. A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism.
Simpson LL
Infect Immun; 1986 Jun; 52(3):858-62. PubMed ID: 3011675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
